GTC Biotherapeutics (fka GTCB)

[cesrph09]

I see no terms there. No terms mean no revenues of substance. No revenues of substance means the IP is being diluted almost as fast as the stock.

Another poster of this board revealed how GTC actually loses money providing a similar service for Merrimack, so the question "can GTC and its shareholders actually afford these developmental contracts" is a considerable one

Somehow I doubt this, I don't mind devil advocate posts, but that is pure speculation, I am assuming you haven't read the agreement.